Using a CRISPR-Cas9 TCT screen we identified CHMP2A, a component of the ESCRT-III complex, as a regulator of GSC and HNSCC cell sensitivity to NK cell-mediated cytotoxicity. This evidence concerns the gene CHMP2A and head and neck squamous cell carcinoma.